Drugs / rMenB+OMV
last change Jul 2008 re-read 2 minutes ago

rMenB+OMV

Vaccine

Developed for
meningococcal infection
Investigated by
Novartis Vaccines

Trials 1 · a red edge is where a trial was stopped

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00433914 Feb → Dec 2007 meningococcal infection Novartis Vaccines Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as rMenB+OMV ClinicalTrials.gov intervention name — accepted as the source's own label NCT00433914
Modality Vaccine “rMenB vaccine with OMV-NZ” NCT00433914